On July 17, 2025, Latham partners discussed significant cases from this Supreme Court term and the business implications of certain decisions.
In this annual webcast, members of our Supreme Court & Appellate Practice — including a former Solicitor General of
The administration has signaled a potential softening of cyber regulation for domestic entities, with increasing focus on national security priorities and preparing for the future.
By Antony (Tony) Kim and Michael H. Rubin
The Trump administration’s focus on reshaping the
On July 16, 2025, Latham partners examined the status of clean energy tax credits.
On July 4, 2025, President Trump signed into law the One Big Beautiful Bill Act (OBBB), which significantly rolls back many of the core tax incentives
If finalized, the rule would eliminate both Obama- and Biden-era limits on GHG emissions from fossil fuel-fired power plants.
By Karl A. Karg, Stacey L. VanBelleghem, Nikki Buffa, Devin M. O’Connor, and G. Jack Mathews
On
The executive order shifts policy on enforcement of criminal regulatory offenses, steering away from criminal enforcement of strict liability offenses in regulatory matters.
By Jennifer L. Bragg, Nicholas McQuaid, and Terra Reynolds
On May 9, 2025, President Trump
The Department of Justice has established a new Civil Rights Fraud Initiative, which will leverage the False Claims Act to investigate and pursue claims against recipients of federal funds who “knowingly violate civil rights laws.”
By Danielle Conley, Terra
General License 25 effectively suspends OFAC sanctions targeting Syria. Stringent US export control restrictions on exports and reexports to Syria remain.
By Les P. Carnegie, Damara Chambers, Charles Claypoole, Andrew P. Galdes, Robert Price, Eric S.
New federal legislation aims to combat the publication of non-consensual deepfakes and mandates notice-and-removal procedures for covered platforms.
By Sy Damle, Andy Gass, Ghaith Mahmood, and Michael H. Rubin
On May 19, 2025, President Trump signed into
The OCC is restoring its former practices and policies under the Bank Merger Act to reinstate expedited merger reviews and streamlined business combination applications.
By Arthur S. Long, Pia Naib, Connor Jobes, and Deric Behar
On May
Recent developments include leadership changes, workforce reductions, and policy shifts at HHS and FDA, reshaping agency operations under President Trump’s administration.
By Nathan A. Beaton, Jennifer L. Bragg, William A. McConagha, and Trevor Thompson
Since his inauguration,